Neurometrix has received FDA clearance for a new smartphone-controlled version of Quell, its wearable for pain relief, the company announced last week. Like its predecessor, the device will use nerve ...

When NeuroMetrix first unveiled the Quell a few years ago, its promise was a drug-free alternative using the body’s own mechanisms to combat chronic pain. Version 2.0 carries on with the same goal; ...

A Massachusetts company is touting a wearable device that it says can alleviate chronic pain, offering a high-tech alternative to opioids. Quell is a drug-free device built by Waltham, Mass.-based ...

The Quell Watch app gives a Quell user the ability to control and monitor their pain relief from their Apple Watch® Quell is a wearable, transcutaneous electrical nerve stimulation (TENS) device for ...

About one-quarter of U.S. adults suffer from frequent knee pain, which limits function, decreases mobility, impacts sleep and reduces quality of life. Chronic knee pain is typically treated with oral ...

WOBURN, Mass., May 31, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) noted publication of an abstract describing partial results from a NIH-funded, multi-site randomized controlled trial of Quell ...

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Quell ® Wearable Pain Relief Technology™ will be featured for the second year in a row at the American ...

WOBURN, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) today announced U.S. Food and Drug Administration (FDA) De Novo authorization to market the Quell neuromodulation device as an ...

ROCKAWAY, N.J., May 13, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the publication of new clinical ...

Being “drug-free” usually references illegal substance abuse, but prescriptions for chronic pain can lead to damaging dependency as well. For those eager to try a pain reliever that doesn’t require ...